-
1Academic Journal
Authors: S. G. Khaspekova, O. N. Shustova, V. V. Bodrova, A. V. Mazurov, С. Г. Хаспекова, О. Н. Шустова, В. В. Бодрова, А. В. Мазуров
Contributors: This work was supported by RFBR grant №20-015-00246, Работа поддержана грантом РФФИ №20-015-00246
Source: Aterotromboz = Atherothrombosis; № 1 (2021); 144-156 ; Атеротромбоз; № 1 (2021); 144-156 ; 2658-5952 ; 2307-1109 ; 10.21518/2307-1109-2021-1
Subject Terms: сердечно-сосудистые заболевания, reticulated platelets, antiplatelet drugs, atherothrombosis, cardiovascular diseases, ретикулярные тромбоциты, антитромбоцитарные препараты, атеротромбоз
File Description: application/pdf
Relation: https://www.aterotromboz.ru/jour/article/view/249/271; Hoffmann J.J. Reticulated platelets: analytical aspects and clinical utility. Clin Chem Lab Med. 2014;52(8):1107–1117. https://doi.org/10.1515/cclm2014-0165.; Buttarello M., Mezzapelle G., Freguglia F., Plebani M. Reticulated platelets and immature platelet fraction: Clinical applications and method limitations. Int J Lab Hematol. 2020;42(4):363–370. https://doi.org/10.1111/ijlh.13177.; Corpataux N., Franke K., Kille A., Valina C.M., Neumann F-J., Nührenberg T., Hochholzer W. Reticulated platelets in medicine: current evidence and further perspectives. J Clin Med. 2020;9(11):3737. https://doi.org/10.3390/jcm9113737.; Ingram M., Coopersmith A. Reticulated platelets following acute blood loss. Br J Haematol. 1969;17(3):225–229. https://doi.org/10.1111/j.1365-2141.1969.tb01366.x.; Kienast J., Schmitz G. Flow cytometric analysis of thiazole orange uptake by platelets: a diagnostic aid in the evaluation of thrombocytopenic disorders. Blood. 1990;75(1):116–121. Available at: https://pubmed.ncbi.nlm.nih.gov/1688494.; Kurata Y., Hayashi S., Kiyoi T., Kosugi S., Kashiwagi H., Honda S., Tomiyama Y. Diagnostic value of tests for reticulated platelets, plasma glycocalicin, and thrombopoietin levels for discriminating between hyperdestructive and hypoplastic thrombocytopenia. Am J Clin Pathol. 2001;115(6):656–664. https://doi.org/10.1309/RAW2-0LQW-8YTX-941V.; Jiménez M.M., Guedán M.J., Martín L.M., Campos J.A., Martínez I.R., Vilella C.T. Measurement of reticulated platelets by simple flow cytometry: an indirect thrombocytopoietic marker. Eur J Intern Med. 2006;17(8):541–544. https://doi.org/10.1016/j.ejim.2006.03.006.; Abe Y., Wada H., Tomatsu H., Sakaguchi A., Nishioka J., Yabu Y. et al. A simple technique to determine thrombopoiesis level using immature platelet fraction (IPF). Thromb Res. 2006;118(4):463–469. https://doi.org/10.1016/j.thromres.2005.09.007.; McCabe D.J. H., Harrison P., Sidhu P.S., Brown M.M., Machin S.J. Circulating reticulated platelets in the early and late phases after ischaemic stroke and transient ischaemic attack. Br J Haematol. 2004;126(6):861–869. https://doi.org/10.1111/j.1365-2141.2004.05137.x.; Guthikonda S., Lev E.I., Patel R., Delao T., Bergeron A.L., Dong J-F., Kleiman N.S. Reticulated platelets and uninhibited COX-1 and COX-2 decrease the antiplatelet effects of aspirin. J Thromb Haemost. 2007;5(3):490–496. https://doi.org/10.1111/j.1538-7836.2007.02387.x.; Ault K.A., Knowles C. In vivo biotinylation demonstrates that reticulated platelets are the youngest platelets in circulation. Exp Hematol. 1995;23(9):996–1001. Available at: https://pubmed.ncbi.nlm.nih.gov/7635185.; Dale G.L., Friese P., Hynes L.A., Burstein S.A. Demonstration that thiazole-orange-positive platelets in the dog are less than 24 hours old. Blood. 1995;85(7):1822–1825. Available at: https://pubmed.ncbi.nlm.nih.gov/7535589/; Heilmann E., Friese P., Anderson S., George J.N., Hanson S.R., Burstein S.A., Dale G.L. Biotinylated platelets: a new approach to the measurement of platelet life span. Br J Haematol. 1993;85(4):729–735. https://doi.org/10.1111/j.1365-2141.1993.tb03216.x.; Guthikonda S., Alviar C.L., Vaduganathan M., Arikan M., Tellez A., DeLao T. et al. Role of reticulated platelets and platelet size heterogeneity on platelet activity after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease. J Am Coll Cardiol. 2008;52(9):743–749. https://doi.org/10.1016/j.jacc.2008.05.031.; Mangalpally K.K. R., Siqueiros-Garcia A., Vaduganathan M., Dong J.F., Kleiman N.S., Guthikonda S. Platelet activation patterns in platelet size sub-populations: differential responses to aspirin in vitro. J Thromb Thrombolysis. 2010;30(3):251–262. https://doi.org/10.1007/s11239-010-0489-x.; Hille L., Lenz M., Vlachos A., Grüning B., Hein L., Neumann F-J. et al. Ultrastructural, transcriptional, and functional differences between human reticulated and non-reticulated platelets. J Thromb Haemost. 2020;18(8):2034–2046. https://doi.org/10.1111/jth.14895.; Bodrova V.V., Shustova O.N., Khaspekova S.G., Mazurov A.V. Platelet reticulated forms, size indexes and functional activity. Interactions in healthy volunteers. Platelets. 2021:1–6. https://doi.org/10.1080/09537104.2021.1922659.; Cesari F., Marcucci R., Caporale R., Paniccia R., Romano E., Gensini G-F., et al. Relationship between high platelet turnover and platelet function in high-risk patients with coronary artery disease on dual antiplatelet therapy. Thromb Haemost. 2008;99(5):930–935. https://doi.org/10.1160/th08-01-0002.; Grove E.L., Hvas A.M., Mortensen S.B., Larsen S.B., Kristensen S.D. Effect of platelet turnover on whole blood platelet aggregation in patients with coronary artery disease. J Thromb Haemost. 2011;9(1):185–191. https://doi.org/10.1111/j.1538-7836.2010.04115.x.; Spectre G., Arnetz L., Östenson C-G., Brismar K., Li N., Hjemdahl P. Twice daily dosing of aspirin improves platelet inhibition in whole blood in patients with type 2 diabetes mellitus and micro- or macrovascular complications. Thromb Haemost. 2011;106(3):491– 499. https://doi.org/10.1160/th11-04-0216.; Cesari F., Marcucci R., Gori A.M., Caporale R., Fanelli A., Casola G. et al. Reticulated platelets predict cardiovascular death in acute coronary syndrome patients. Insights from the AMI-Florence 2 Study. Thromb Haemost. 2013;109(5):846–853. https://doi.org/10.1160/th12-09-0709.; Lador A., Leshem L.D., Spectre G., Abelow A., Kornowski R., Lev E.I. Characterization of surface antigens of reticulated immature platelets. J Thromb Thrombolysis. 2017;44(3):291–297. https://doi.org/10.1007/s11239-017-1533-x.; McBane R. D., Gonzalez C., Hodge D.O., Wysokinski W.E. Propensity for young reticulated platelet recruitment into arterial thrombi. J Thromb Thrombolysis. 2014;37(2):148–154. https://doi.org/10.1007/s11239-013-0932-x.; Armstrong P.C., Hoefer T., Knowles R.B., Tucker A.T., Hayman M.A., Ferreira P.M. et al. Newly formed reticulated platelets undermine pharmacokinetically shortlived antiplatelet therapies. Arterioscler Thromb Vasc Biol. 2017;37(5):949–956. https://doi.org/10.1161/atvbaha.116.308763.; Freynhofer M.K., Gruber S.C., Grove E.L., Weiss T.W., Wojta J., Huber K. Antiplatelet drugs in patients with enhanced platelet turnover: biomarkers versus platelet function testing. Thromb Haemost. 2015;114:459– 468. https://doi.org/10.1160/th15-02-0179.; Hannawi B., Hannawi Y., Kleiman N.S. Reticulated platelets: changing focus from basics to outcomes. J Thromb Haemost. 2018;118(9):1517–1527. https://doi.org/10.1055/s-0038-1667338.; Würtz M., Wulff L.N., EGrove.L., Kristensen S.D., Hvas A.M. Influence of renal function and platelet turnover on the antiplatelet effect of aspirin. Thromb Res. 2012;129(4):434–440. https://doi.org/10.1016/j.thromres.2011.07.019.; Zanazzi M., Cesari F., Rosso G., Farsetti S., Caroti L., Gori A.M. et al. Reticulated platelets and platelet reactivity in renal transplant recipients receiving antiplatelet therapy. Transplant Proc. 2010;42(4):1156–1157. https://doi.org/10.1016/j.transproceed.2010.03.042.; Ibrahim H., Nadipalli S., DeLao T., Guthikonda S., Kleiman N.S. Immature platelet fraction (IPF) determined with an automated method predicts clopidogrel hyporesponsiveness. J Thromb Thrombolysis. 2012;33(2):137–142. https://doi.org/10.1007/s11239-011-0665-7.; Freynhofer M.K., Bruno V., Brozovic I., Jarai R., Vogel B., Farhan S. et al. Variability of on-treatment platelet reactivity in patients on clopidogrel. Platelets. 2014;25(5):328–336. https://doi.org/10.3109/09537104.2013.827781.; Stratz C., Bömicke T., Younas I., Kittel A., Amann M., Valina C.M. et al. Comparison of immature platelet count to established predictors of platelet reactivity during thienopyridine therapy. J Am Coll Cardiol. 2016;68(3):286–293. https://doi.org/10.1016/j.jacc.2016.04.056.; Funck-Jensen K.L., Dalsgaard J., Grove E.L., Hvas A.M., Kristensen S.D. Increased platelet aggregation and turnover in the acute phase of ST-elevation myocardial infarction. Platelets. 2012;24(7):528–537. https://doi.org/10.3109/09537104.2012.738838.; Verdoia M., Pergolini P., Nardin M., Rolla R., Barbieri L., Schaffer A. et al. Impact of diabetes on immature platelets fraction and its relationship with platelet reactivity in patients receiving dual antiplatelet therapy. J Thromb Thrombolysis. 2016;42(2):245–253. https://doi.org/10.1007/s11239-016-1348-1.; Mijovic R., Kovacevic N., Zarkov M., Stosic Z., Cabarkapa V., Mitic G. Reticulated platelets and antiplatelet therapy response in diabetic patients. J Thromb Thrombolysis. 2015;40(2):203–210. https://doi.org/10.1007/s11239-014-1165-3.; Perl L., Lerman-Shivek H., Rechavia E., Vaduganathan M., Leshem-Lev D., Zemer-Wassercug N. et al. Response to prasugrel and levels of circulating reticulated platelets in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2014;63(6):513–517. https://doi.org/10.1016/j.jacc.2013.07.110.; Bernlochner I., Goedel A., Plischke C., Schupke S., Haller B., Schulz C. et al. Impact of immature platelets on platelet response to ticagrelor and prasugrel in patients with acute coronary syndrome. Eur Heart J. 2015;36(45):3202–3210. https://doi.org/10.1093/eurheartj/ehv326.; Vaduganathan M., Zemer-Wassercug N., Rechavia E., Lerman-Shivek H., Perl L., Leshem-Lev D. et al. Relation between ticagrelor response and levels of circulating reticulated platelets in patients with non-ST elevation acute coronary syndromes. J Thromb Thrombolysis. 2015:40(2):211–217. https://doi.org/10.1007/s11239-015-1178-6.; Eisen A., Lerman-Shivek H., Perl L., Rechavia E., Leshem-Lev D., Zemer-Wassercug N. et al. Circulating reticulated platelets over time in patients with myocardial infarction treated with prasugrel or ticagrelor. J Thromb Thrombolysis. 2015;40(1):70–75. https://doi.org/10.1007/s11239-014-1156-4.; Verdoia M., Pergolini P., Rolla R., Suryapranata H., Kedhi E., De Luca G. Impact of immature platelet fraction on platelet reactivity during prasugrel maintenance treatment. Platelets. 2019;30(7):915–922. https://doi.org/10.1080/09537104.2018.1535707.; Stratz C., Nührenberg T., Valina C.M., Löffelhardt N., Mashayekhi K., Ferenc M. et al. Impact of reticulated platelets on the antiplatelet effect of the intravenous P2Y12-receptor inhibitor cangrelor. Thromb Haemost. 2018;118(2):362–368. https://doi.org/10.1160/th17-07-0466.; Lakkis N., Dokainish H., Abuzahra M., Tsyboulev V., Jorgensen J., Ponce De Leon A., Saleem A. Reticulated platelets in acute coronary syndrome: a marker of platelet activity. J Am Coll Card. 2004;44(10):2091– 2093. https://doi.org/10.1016/j.jacc.2004.05.033.; Grove E.L., Hvas A.M., Kristensen S.D. Immature platelets in patients with acute coronary syndromes. Thromb Haemost. 2009;101(1):151–156. Available at: https://pubmed.ncbi.nlm.nih.gov/19132202.; Ramon G.L., Martin-Herrero F., Gonzalez-Lopez T. J., Olazabal1 J., Diez-Campelo M., Pabon P. et al. The role of immature platelet fraction in acute coronary syndrome. Thromb Haemost. 2010;103(1):247–249. https://doi.org/10.1160/th09-02-0124.; Berny-Lang M.A., Darling C.E., Frelinger A.L. 3rd, Barnard M.R., Smith C.S., Michelson A.D. Do immature platelet levels in chest pain patients presenting to the emergency department aid in the diagnosis of acute coronary syndrome? Int J Lab Hematol. 2015;37(1):112–119. https://doi.org/10.1111/ijlh.12250.; Ibrahim H., Nadipalli S., Usmani S., DeLao T., Green L., Kleiman N.S. Detection and quantification of circulating immature platelets: agreement between flow cytometric and automated detection. J Thromb Thrombolysis. 2016;42(1):77–83. https://doi.org/10.1007/s11239-016-1338-3.; Verdoia M., Nardin M., Rolla R., Marino P., Bellomo G., Suryapranata H., De Luca G. Immature platelet fraction and the extent of coronary artery disease: A single centre study. Atherosclerosis. 2017;260:110–115. https://doi.org/10.1016/j.atherosclerosis.2017.03.044.; Martin J.F., Kristensen S.D., Mathur A., Grove E.L., Fizzah A.C. The causal role of megakaryocyte-platelet hyperactivity in acute coronary syndromes. Nat Rev Cardiol. 2012;9(11):658–670. https://doi.org/10.1038/nrcardio.2012.131.; Trowbridge E.A., Slater D.N., Kishk Y.T., Woodcock B.W., Martin J.F. Platelet production in myocardial infarction and sudden cardiac death. Thromb Haemost. 1984;52(2):167–171. Available at: https://pubmed.ncbi.nlm.nih.gov/6523435/; Bath P.M., Gladwin A.M., Carden N., Martin J.F. Megakaryocyte DNA content is increased in patients with coronary artery atherosclerosis. Cardiovasc Res. 1994;28(9):1348–1352. https://doi.org/10.1093/cvr/28.9.1348.; Brown A.S., Hong Y., Belder A., Beacon H., Beeso J., Sherwood R. et al. Megakaryocyte Ploidy and Platelet Changes in Human Diabetes and Atherosclerosis. Arterioscler Thromb Vasc Biol. 1997;17(4):802–807. https://doi.org/10.1161/01.atv.17.4.802.; Van Pampus E.C., Huijgens P.C., Zevenbergen A., Verheugtt F.W., Langenhuijsen M.M. Circulating human megakaryocytes in cardiac diseases. Eur J Clin Invest. 1994;24(5):345–349. https://doi.org/10.1111/j.1365-2362.1994.tb01095.x.; Sinzinger H., Virgolini I., Fitscha P. Platelet kinetics in patients with atherosclerosis. Thromb Res. 1990;57(4):507–516. https://doi.org/10.1016/0049-3848(90)90068-n.; López-Jiménez R.A., Martín-Herrero F., GonzálezPorras J.R., Sánchez-Barba M., Pabón-Osuna C.M. Immature platelet fraction: a new prognostic marker in acute coronary syndrome. Rev Esp Cardiol (Engl Ed). 2013;66(2):147–148. https://doi.org/10.1016/j.rec.2012.05.014.; Ibrahim H., Schutt R.S., Hannawi B., DeLao T., Barker C.M., Kleiman N.S. Association of immature platelets with adverse cardiovascular outcomes. J Am Coll Cardiol. 2014;64(20):2122–2129. https://doi.org/10.1016/j.jacc.2014.06.1210.; Freynhofer M.K., Iliev L., Bruno V., Rohla M., Egger F., Weiss T.W. et al. Platelet turnover predicts outcome after coronary intervention. Thromb Haemost. 2017;117(5):923–933. https://doi.org/10.1160/th16-10-0785.; Tscharre M., Farhan S., Bruno V., Rohla M., Egger F., Weiss T.W. et al. Impact of platelet turnover on longterm adverse cardiovascular outcomes in patients undergoing percutaneous coronary intervention. Eur J Clin Invest. 2019;49(9):13157. https://doi.org/10.1111/eci.13157.; Perl L., Matatov Y., Koronowski R., Lev E.I., Solodky A. Prognostic significance of reticulated platelet levels in diabetic patients with stable coronary artery disease. Platelets. 2020;31(8):1012–1018. https://doi.org/10.1080/09537104.2019.1704712.; Zhao Y., Lai R., Zhang Y., Shi D. The prognostic value of reticulated platelets in patients with coronary artery disease: a systematic review and meta-analysis. Front Cardiovasc Med. 2020;7:578041. https://doi.org/10.3389/fcvm.2020.578041.; https://www.aterotromboz.ru/jour/article/view/249
-
2Academic Journal
Authors: Tarasenko, S.O., Dubrov, S.O., Suslov, G.G., Maznichenko, V.A.
Source: EMERGENCY MEDICINE; Vol. 16 No. 7-8 (2020); 93-105
МЕДИЦИНА НЕОТЛОЖНЫХ СОСТОЯНИЙ; Том 16 № 7-8 (2020); 93-105
МЕДИЦИНА НЕВІДКЛАДНИХ СТАНІВ; Том 16 № 7-8 (2020); 93-105Subject Terms: 03 medical and health sciences, 0302 clinical medicine, гепарины, антитромбоцитарные препараты, антагонисты витамина К, новые оральные антикоагулянты, периоперационный менеджмент, гепарини, антитромбоцитарні препарати, антагоністи вітаміну К, нові оральні антикоагулянти, пері-операційний менеджмент, heparins, antiplatelet agents, vitamin K antagonists, new oral anticoagulants, perioperative management, 3. Good health
File Description: application/pdf
-
3Academic Journal
Source: Pain, Anaesthesia and Intensive Care; No. 1(94) (2021); 65-77
PAIN, ANAESTHESIA & INTENSIVE CARE; № 1(94) (2021); 65-77Subject Terms: периоперационный менеджмент, новые оральные антикоагулянты, perioperative management, періопераційної менеджмент, нові оральні антікогулянтов, 3. Good health, антагонисты витамина К, vitamin K antagonists, гепарини, антитромбоцитарні препарати, антитромбоцитарные препараты, heparins, new oral anti-coagulants, antiplatelet agents, антагоністи вітаміну К, гепарины
File Description: application/pdf
Access URL: http://jpaic.aaukr.org/article/view/230618
-
4Academic Journal
Source: Качественная клиническая практика, Vol 0, Iss 1, Pp 60-70 (2018)
Subject Terms: острый коронарный синдром, потребление лекарственных средств, антитромбоцитарные препараты, аспирин, тиклопидин, клопидогрел, Medical technology, R855-855.5, Pharmacy and materia medica, RS1-441
File Description: electronic resource
-
5Academic Journal
Authors: S. K. Zyryanov, E. V. Dumchenko
Source: Качественная клиническая практика, Vol 0, Iss 2, Pp 29-34 (2018)
Subject Terms: исследование потребления лекарств, обзор потребления лекарственных средств, фармацевтический рынок, антитромбоцитарные препараты, тиклопидин, клопидогрел, тикагрелор, россия, drug utilization research, survey of drug usage, survey of drug consumption, pharmaceutical market, antiplatelet drugs, ticlopidine, clopidogrel, ticagrelor, russia, Medical technology, R855-855.5, Pharmacy and materia medica, RS1-441
File Description: electronic resource
-
6Report
Subject Terms: острый инфаркт миокарда, percutaneous coronary intervention, двойная антитромбоцитарная терапия, acute myocardial infarction, acetylsalicylic acid, antiplatelet drugs, острый коронарный синдром, dual antiplatelet therapy, риск кровотечений, ticagrelor, acute coronary syndrome, тикагрелор, bleeding risk, чрескожное коронарное вмешательство, антитромбоцитарные препараты, ацетилсалициловая кислота
-
7Academic Journal
Source: Качественная клиническая практика, Vol 0, Iss 1, Pp 60-70 (2018)
Subject Terms: острый коронарный синдром, потребление лекарственных средств, антитромбоцитарные препараты, аспирин, тиклопидин, клопидогрел, Medical technology, R855-855.5, Pharmacy and materia medica, RS1-441
-
8Academic Journal
Authors: S. K. Zyryanov, E. V. Dumchenko, С. К. Зырянов, Е. В. Думченко
Source: Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice; № 2 (2017); 29-34 ; Качественная клиническая практика; № 2 (2017); 29-34 ; 2618-8473 ; 2588-0519
Subject Terms: Russia, обзор потребления лекарственных средств, фармацевтический рынок, антитромбоцитарные препараты, тиклопидин, клопидогрел, тикагрелор, Россия, drug utilization research, survey of drug usage, survey of drug consumption, pharmaceutical market, antiplatelet drugs, ticlopidine, clopidogrel, ticagrelor
File Description: application/pdf
Relation: https://www.clinvest.ru/jour/article/view/85/85; Аналитический отчет «Тенденции и практические аспекты развития российского фармацевтического рынка [Электронный ресурс]. - Режим доступа: https://www2.deloitte.com/ru/ru/pages/life-sciences-and-healthcare/articles/russian-pharmaceutical-industry-2015.html (дата обращения: 15.10.2016).; Атлас здоровья в Европе - WHO/Europe - World Health Organization [Электронный ресурс]. Режим доступа: http://www.euro.who.int/_data/assets/pdf (дата обращения: 10.08.2016).; Государственные закупки лекарственных средств. DSM Group [Электронный ресурс]. Режим доступа: http://www.dsm.ru/news/343/ (дата обращения: 5.12.2016).; Государственный реестр лекарственных средств [Электронный ресурс]. Режим доступа: grls.rosminzdrav.ru/grls.aspx (дата обращения 12.05.2016).; Здравоохранение в России. Статистический сборник. М.: Росстат, 2015; 175.; Мировая статистика здравоохранения отчет ВОЗ за 2016 год [Электронный ресурс]. Режим доступа: http://www.who.int/gho/publications/world_health_ statistics/en/ (дата обращения: 10.08.2016).; Показатели фармацевтического рынка антитромбоцитарных препаратов за 2014. IMS Market share chart [Электронный ресурс]. Режим доступа: http:// www.imshealth.com (дата обращения: 21.09.2016).; Показатели фармацевтического рынка антитромбоцитарных препаратов за 2015. IMS Market share chart [Электронный ресурс]. Режим доступа: http:// www.imshealth.com (дата обращения: 21.09.2016).; Показатели фармацевтического рынка антитромбоцитарных препаратов за 2016. IMS Market share chart [Электронный ресурс]. Режим доступа: http:// www.imshealth.com (дата обращения: 10.05.2017).; Фармацевтический рынок России. Итоги 2015 года: аналитический обзор. DSM Group [Электронный ресурс]. Режим доступа: http://www.dsm.ru/docs/ analytics/Annual_report_2015_DSM_web.pdf (дата обращения: 15.10.2016).; Фармацевтический рынок России. Итоги 2016 года: аналитический обзор. DSM Group [Электронный ресурс]. Режим доступа: http://dsm.ru/docs/ analytics/Annual_Report_2016_rus.pdf (дата обращения: 15.04.2017).; Чеберда А.Е. Исследования потребления лекарственных средств. Качественная клиническая практика. 2017; 1: 42-45.; https://www.clinvest.ru/jour/article/view/85
Availability: https://www.clinvest.ru/jour/article/view/85
-
9Academic Journal
Authors: D. H. Aynetdinova, A. E. Udovichenko, V. A. Sulimov
Source: Рациональная фармакотерапия в кардиологии, Vol 3, Iss 3, Pp 52-59 (2015)
Subject Terms: антитромбоцитарные препараты, клопидогрель, резистентность к ацетилсалициловой кислоте, Therapeutics. Pharmacology, RM1-950, Diseases of the circulatory (Cardiovascular) system, RC666-701
File Description: electronic resource
-
10Academic Journal
Authors: A. V. Shulkin, E. N. Yakusheva, N. M. Popova
Source: Рациональная фармакотерапия в кардиологии, Vol 9, Iss 6, Pp 701-707 (2015)
Subject Terms: гликопротеин-P, ABCB1 белок, полиморфизм гена MDR1, сердечные гликозиды, антитромбоцитарные препараты, антикоагулянты, Therapeutics. Pharmacology, RM1-950, Diseases of the circulatory (Cardiovascular) system, RC666-701
File Description: electronic resource
-
11Academic Journal
Authors: N. M. Popova, A. V. Shulkin, E. N. Yakusheva
Source: Рациональная фармакотерапия в кардиологии, Vol 9, Iss 6, Pp 701-707 (2015)
Subject Terms: anticoagulants, полиморфизм гена MDR1, сердечные гликозиды, RM1-950, abcb1 protein, polymorphisms of the mdr1 gene, cardiac glycosides, 3. Good health, 03 medical and health sciences, 0302 clinical medicine, p-glycoprotein, RC666-701, антитромбоцитарные препараты, Diseases of the circulatory (Cardiovascular) system, Therapeutics. Pharmacology, гликопротеин-P, antiplatelet agents, ABCB1 белок, антикоагулянты
Access URL: https://www.rpcardio.com/jour/article/download/302/317
https://doaj.org/article/25356f1d4f094927b55d3fc38430487b
https://doaj.org/article/10299c9b74574c54b8e6ea9e3e335f70
https://core.ac.uk/display/87816569
https://www.rpcardio.com/jour/article/download/302/317
https://www.rpcardio.com/jour/article/view/302 -
12Academic Journal
Authors: D. H. Aynetdinova, A. E. Udovichenko, V. A. Sulimov
Source: Рациональная фармакотерапия в кардиологии, Vol 3, Iss 3, Pp 52-59 (2015)
Subject Terms: clopidogrel, 03 medical and health sciences, 0302 clinical medicine, резистентность к ацетилсалициловой кислоте, RC666-701, антитромбоцитарные препараты, Diseases of the circulatory (Cardiovascular) system, antiplatelet drugs, Therapeutics. Pharmacology, RM1-950, клопидогрель, resistance to acetylsalicylic acid, 3. Good health
-
13Academic Journal
ДВОЙНАЯ И ТРОЙНАЯ АНТИТРОМБОТИЧЕСКАЯ ТЕРАПИЯ ПРИ ФИБРИЛЛЯЦИИ ПРЕДСЕРДИЙ И ОСТРОМ КОРОНАРНОМ СИНДРОМЕ
Authors: ЕНИСЕЕВА ЕЛЕНА СЕРГЕЕВНА
File Description: text/html
-
14Academic Journal
ДВОЙНАЯ И ТРОЙНАЯ АНТИТРОМБОТИЧЕСКАЯ ТЕРАПИЯ ПРИ ФИБРИЛЛЯЦИИ ПРЕДСЕРДИЙ И ОСТРОМ КОРОНАРНОМ СИНДРОМЕ
Source: Сибирский медицинский журнал (Иркутск).
Subject Terms: ОСТРЫЙ КОРОНАРНЫЙ СИНДРОМ,ФИБРИЛЛЯЦИЯ ПРЕДСЕРДИЙ,ОРАЛЬНЫЕ АНТИКОАГУЛЯНТЫ,АНТИТРОМБОЦИТАРНЫЕ ПРЕПАРАТЫ,ACUTE CORONARY SYNDROME,ATRIAL FIBRILLATION,ORAL ANTICOAGULANTS,ANTIPLATELET DRUGS, 3. Good health
File Description: text/html
-
15Academic Journal
Authors: Щулькин, Алексей, Якушева, Елена, Попова, Наталья
Subject Terms: ГЛИКОПРОТЕИН-P, ABCB1 БЕЛОК, ПОЛИМОРФИЗМ ГЕНА MDR1, СЕРДЕЧНЫЕ ГЛИКОЗИДЫ, АНТИТРОМБОЦИТАРНЫЕ ПРЕПАРАТЫ, АНТИКОАГУЛЯНТЫ
File Description: text/html
-
16Academic Journal
Authors: Ханюков, А.
Subject Terms: ХРОНіЧНА іШЕМіЧНА ХВОРОБА СЕРЦЯ, АТЕРОСКЛЕРОТИЧНЕ УРАЖЕННЯ АРТЕРіЙ НИЖНіХ КіНЦіВОК, МЕДИКАМЕНТОЗНЕ ЛіКУВАННЯ, ОПЕРАТИВНЕ ЛіКУВАННЯ, АНТИТРОМБОТИЧНА ТЕРАПіЯ, СТАТИНИ, ХРОНИЧЕСКАЯ ИШЕМИЧЕСКАЯ БОЛЕЗНЬ СЕРДЦА, АТЕРОСКЛЕРОТИЧЕСКОЕ ПОРАЖЕНИЕ АРТЕРИЙ НИЖНИХ КОНЕЧНОСТЕЙ, МЕДИКАМЕНТОЗНОЕ ЛЕЧЕНИЕ, ОПЕРАТИВНОЕ ЛЕЧЕНИЕ, АНТИТРОМБОЦИТАРНЫЕ ПРЕПАРАТЫ, СТАТИНЫ
File Description: text/html
-
17Academic Journal
Authors: Ханюков, А., Писаревская, О.
Subject Terms: ХРОНИЧЕСКАЯ ИШЕМИЧЕСКАЯ БОЛЕЗНЬ СЕРДЦА, АТЕРОСКЛЕРОТИЧЕСКОЕ ПОРАЖЕНИЕ АРТЕРИЙ НИЖНИХ КОНЕЧНОСТЕЙ, САХАРНЫЙ ДИАБЕТ, ЛЕЧЕНИЕ, АНТИТРОМБОЦИТАРНЫЕ ПРЕПАРАТЫ, СТАТИНЫ
File Description: text/html
-
18Academic Journal
Authors: Д. Ю. Белоусов, О. И. Медников
Source: Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice; № 1 (2003); 60-70 ; Качественная клиническая практика; № 1 (2003); 60-70 ; 2618-8473 ; 2588-0519
Subject Terms: клопидогрел, потребление лекарственных средств, антитромбоцитарные препараты, аспирин, тиклопидин
Relation: Alpert J.S., et al. Myocardial infarction redefined: A consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Journal of the American College of Cardiology. 2000;36:959-969.; American Heart Association (AHA). 2001 heart and stroke statistical update. Dallas: American Heart Association. 2000.; Antiplatelet Trialists’ Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients British Medical Journal. 12 Jan 2002, Vol 324: p 71-86.; Barakat K., et al. Acute myocardial infarction in women: contribution of treatment variables to adverse outcome. American Heart Journal. 2000;140:740-746.; Braunwald E. Shattuck Lecture: cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. New England Journal of Medicine. 1997;337:1360-1369.; Capewell S., et al. Trends in case-fatality in 117,718 patients admitted with acute myocardial infarction in Scotland. European Society of Cardiology. 2000;21:1833-1840.; CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet. 1996;348:1329.; Chandra N.C., et al. Observations of the treatment of women in the United States with myocardial infarction: a report from the National Registry of Myocardial Infarction-I. Archives of Internal Medicine. 1998;158:981-988.; Choudhury L. Myocardial infarction in young patients. American Journal of Medicine. 1999;107:254.; Cooper R., et al. Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States: findings of the National Conference on Cardiovascular Disease Prevention. Circulation. 2000;102:3137-3147.; CURE Study Investigators. The clopidogrel in unstable angina to prevent recurrent events (CURE) trial programme. Eur Heart J 2000; 21: 2033-41.; Ducimetiere P., et al. Why mortality from heart disease is low in France. British Medical Journal. 2000;320:249-249.; Ezzati T.M., et al. Sample design: Third National Health and Nutrition Examination Survey. Vital Health Stat. 1992;1-35.; Fonarow G.C., et al. Use of lipid lowering medications at discharge in patients with acute myocardial infarction. Circulation. 2001;103:38-44.; Ford E.S., et al. Prevalence of nonfatal coronary heart disease among American adults. American Heart Journal. 2000;139:371-377.; Fukiyama K., et al. Incidence and long-term prognosis of initial stroke and acute myocardial infarction in Okinawa, Japan. Hypertension Research. 2000;23:127-135.; Furman M.I., et al. Twenty-two year (1975-1997) trends in the incidence, in-hospital and long-term case fatality rates from initial Q-wave and non-Q-wave myocardial infarction: A multi-hospital, community-wide perspective. Journal of the American- College of Cardiology. 2001;37:1571-1580.; Gersh B.J. The changing late prognosis of acute myocardial infarction: implications and mechanisms. European Heart Journal. 1995;16:50-53.; Goldberg R.J. A two-decades (1975 to 1995) long experience in the incidence, in-hospital and long-term case-fatality rates of acute myocardial infarction: A community-wide perspective. Journal of the American College of Cardiology. 1999;33:1533-1539.; Gunter N., et al. Cooperative cardiovascular project. Journal of the South Carolina Medical Association. 1997;93(5):177-179.; Heidenreich P.A., McClellan M. Trends in treatment and outcomes for acute myocardial infarction: 1975-1995. American Journal of Medicine. 2001;110:165-174.; Hosoda S., et al. Follow-up of 2,733 patients with myocardial infarction. Japanese Circulation Journal. 1995;59:121-129.; Joint Symposium: European Society of Cardiology/American College of Cardiology. Presented at ACC 2001/50th Annual Scientific Session; March 18-21, 2001; Orlando, FL.; Kimura Y., et al. Demographic study of first-ever stroke and acute myocardial infarction on Okinawa, Japan. Internal Medicine. 1998;37:736-745.; Mehta S.R., Yusuf S., Peters R.J.G. et al for the CURE investigators. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: The PCI-CURE study. Lancet 2001; 358: 527-33.; Meier M.A. The new definition of myocardial infarction: what does it mean clinically? Presented at ACC 2001/ 50th. Annual Scientific Session. March 18-21, 2001; Orlando, FL.; Nakamura Y., et al. Comparison between Japan and North America in the post-hospital course after recovery from an acute coronary event. International Journal of Cardiology. 1996;55:245-254.; National Centre for Social Research. Health Survey of England 1998: cardiovascular disease. Department of Epidemiology and Public Health, Royal Free and University College Medical School The Stationary Office, London. 1998.; National Heart, Lung and Blood Institute (NHLBI). Morbidity and Mortality: 2000 Chartbook on Cardiovascular, Lung, and Blood Diseases. Bethesda, MD: Public Health Service, National Institutes of Health; 2000:17-35.; Olsson L., et al. Validity of a postal questionnaire with regard to the prevalence of myocardial infarction in a general population sample. European Heart Journal. 1989;10:1011-1016.; Pepine C.I., et al. Changing myocardial infarction population characteristics: reasons and implications. American Heart Journal. 1997;134:S1.; Perez G., et al. Myocardial Infarction in Girona, Spain: attack rate, mortality rate and 28-day case fatality in 1988. Journal of Clinical Epidemiology. 1993;46:1173.; Phibbs B., et al. Q-wave and non-Q wave myocardial infarction: a meaningless distinction. Journal of the American College of Cardiology. 1999;33:576-582.; Rosamond W.D., et al. Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987-1994. New England Journal of Medicine. 1998;339:861867.; Sala J., et al. Improvement in survival after myocardial infarction between 1978-1985 and 1986-1988 in the REGICOR Study. European Heart Journal. 1995;16:779-784.; Scrutino D., et al. Ticlopidine versus aspirin after myocardial infarction (STAMI) trial. Journal of the American College of Cardiology. 2001;37:1259-1265.; Tanabe M., et al. [Epidemiology of acute coronary syndrome]. Nippon Rinsho. 1998;56:2681-2685.; The Clopidogrel in Unstable Angina to Prevent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without STBsegment elevation. N Engl J Med 2001; 345: 494-502.; Tunstall-Pedoe H., et al. Contribution of trends in survival and coronary event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA Project populations. Lancet. 1999;353:1547-1557.; United Nations (U.N.), Population Division, Department of Economics and Social Affairs. Sex and age quinquennial 1950-2050 (The 1998 revision), 1998.; Vaccarino V., et al. Long-term outcome of myocardial infarction in women and men: a population perspective. American Journal of Epidemiology. 2000;152:965-973.; van der Pal-de Bruin K.M., et al. The incidence of suspected myocardial infarction in Dutch general practice in the period 1978-1994. European Heart Journal. 1998;19:429-434.; Volmink J.A. Coronary event and case fatality rates in an English population: results of the Oxford Myocardial Infarction Incidence Study. Heart. 1998;80:40; Wiesner G., et al. Note on the myocardial infarction scene in the Federal Republic of Germany: prevalence, incidence, trends, comparison between Eastern and Western Germany [Zum Herzinfarktgeschehen in der Bundesrepublik Deutschland: Pravalenz, Inzidenz, Trend, Ost-West-Vergleich]. Gesundheitswesen. 1999;61:S72-S78.; Здоровье населения России и деятельность учреждения здравоохранения в 1999 (2000) г. (статистические материалы). М., 1999 (2000); Импорт антиромбоцитарных средств (2002), ООО 'Даймонд Вижн', www.d-vision.ru; Прайс-лист 'ЦВ Протек' от 27 января 2003 г., www.protek.ru; Pietro Minuz, Maurizio Degan, Stefania Gaino, Alessandra Meneguzzi, Valeria Zuliani, Clara Lechi Santonastaso, Piero Del Soldato, Alessandro Lechi NCX4016 (NO-aspirin) inhibits thrombox ane biosynthesis and tissue factor expression and activity in human monocytes. Med Sci Monit, 2001; 7(4): 573-577; Основы клинической фармакологии и рациональной фармакотерапии, под ред. Ю.Б.Белоусова, М.В.Леоновой, Издательство 'Бионика', М.-2002, стр. 187; Рекомендации по лечению острого коронарного синдрома без стойкого подъема сегмента ST на ЭКГ. ВНОК. Российский национальный конгресс кардиологов 11 октября 2001г., www.cardiosite.ru; Рекомендации Европейского общества кардиологов Экспертный комитет по разработке практических рекомендаций и проведению методических конференций с целью повышения качества лечения в европейских странах Рекомендации по диагностике и лечению хронической сердечной недостаточности. Сердечная недостаточность. Consilium Medicum. Том 1/N 6/2001, www.consilium-medicum.com/media/heart/01_06/251.shtml; rd International Summit on Atherothrombosis, 12-13 April 2003, Madrid, Spain. Abstract book.; https://www.clinvest.ru/jour/article/view/270
Availability: https://www.clinvest.ru/jour/article/view/270
-
19Academic Journal
Authors: Айнетдинова, Д., Удовиченко, А., Сулимов, В.
Subject Terms: АНТИТРОМБОЦИТАРНЫЕ ПРЕПАРАТЫ, КЛОПИДОГРЕЛЬ, РЕЗИСТЕНТНОСТЬ К АЦЕТИЛСАЛИЦИЛОВОЙ КИСЛОТЕ
File Description: text/html
-
20Academic Journal
Source: Рациональная фармакотерапия в кардиологии.
Subject Terms: ГЛИКОПРОТЕИН-P, ABCB1 БЕЛОК, ПОЛИМОРФИЗМ ГЕНА MDR1, СЕРДЕЧНЫЕ ГЛИКОЗИДЫ, АНТИТРОМБОЦИТАРНЫЕ ПРЕПАРАТЫ, АНТИКОАГУЛЯНТЫ, 3. Good health
File Description: text/html
